Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.072 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.065 | 0.7 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.071 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |